SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,730 | -9.5% | 336 | -14.5% | 0.02% | -8.0% |
| Q2 2023 | $45,006 | -91.7% | 393 | -93.4% | 0.02% | -84.1% |
| Q4 2021 | $540,000 | -35.1% | 6,000 | -33.3% | 0.16% | -25.6% |
| Q3 2021 | $832,000 | -23.5% | 9,000 | -35.7% | 0.21% | -28.5% |
| Q2 2021 | $1,088,000 | +53.7% | 14,000 | +47.4% | 0.30% | +23.4% |
| Q1 2021 | $708,000 | +471.0% | 9,500 | +1210.3% | 0.24% | +359.6% |
| Q4 2020 | $124,000 | +396.0% | 725 | +314.3% | 0.05% | +333.3% |
| Q3 2020 | $25,000 | – | 175 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |